B cell subsets in atherosclerosis
- PMID: 23248624
- PMCID: PMC3518786
- DOI: 10.3389/fimmu.2012.00373
B cell subsets in atherosclerosis
Abstract
Atherosclerosis, the underlying cause of heart attacks and strokes, is a chronic inflammatory disease of the artery wall. Immune cells, including lymphocytes modulate atherosclerotic lesion development through interconnected mechanisms. Elegant studies over the past decades have begun to unravel a role for B cells in atherosclerosis. Recent findings provide evidence that B cell effects on atherosclerosis may be subset-dependent. B-1a B cells have been reported to protect from atherosclerosis by secretion of natural IgM antibodies. Conventional B-2 B cells can promote atherosclerosis through less clearly defined mechanism that may involve CD4 T cells. Yet, there may be other populations of B cells within these subsets with different phenotypes altering their impact on atherosclerosis. Additionally, the role of B cell subsets in atherosclerosis may depend on their environmental niche and/or the stage of atherogenesis. This review will highlight key findings in the evolving field of B cells and atherosclerosis and touch on the potential and importance of translating these findings to human disease.
Keywords: B cell; IgM; atherosclerosis; cytokines; lipids.
Figures
Similar articles
-
Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.Immunobiology. 2016 Sep;221(9):1014-33. doi: 10.1016/j.imbio.2016.05.010. Epub 2016 May 24. Immunobiology. 2016. PMID: 27262513 Review.
-
Opposing roles of B lymphocyte subsets in atherosclerosis.Autoimmunity. 2017 Feb;50(1):52-56. doi: 10.1080/08916934.2017.1280669. Autoimmunity. 2017. PMID: 28166680 Review.
-
CD40 signaling in vascular cells: a key role in atherosclerosis?Atherosclerosis. 1998 Apr;137 Suppl:S89-95. doi: 10.1016/s0021-9150(97)00309-2. Atherosclerosis. 1998. PMID: 9694547 Review.
-
B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.Circ Res. 2011 Sep 30;109(8):830-40. doi: 10.1161/CIRCRESAHA.111.248542. Epub 2011 Aug 25. Circ Res. 2011. PMID: 21868694
-
Interleukin-10 production and T cell-suppressive capacity in B cell subsets from atherosclerotic apoE -/- mice.Immunol Res. 2017 Oct;65(5):995-1008. doi: 10.1007/s12026-017-8939-6. Immunol Res. 2017. PMID: 28744806
Cited by
-
Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical study.Front Immunol. 2022 Sep 15;13:968815. doi: 10.3389/fimmu.2022.968815. eCollection 2022. Front Immunol. 2022. PMID: 36189218 Free PMC article.
-
Executable models of immune signaling pathways in HIV-associated atherosclerosis.NPJ Syst Biol Appl. 2022 Sep 21;8(1):35. doi: 10.1038/s41540-022-00246-5. NPJ Syst Biol Appl. 2022. PMID: 36131068 Free PMC article.
-
B Lymphocyte-Deficiency in Mice Causes Vascular Dysfunction by Inducing Neutrophilia.Biomedicines. 2021 Nov 14;9(11):1686. doi: 10.3390/biomedicines9111686. Biomedicines. 2021. PMID: 34829915 Free PMC article.
-
Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia.Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):6-18. doi: 10.1161/ATVBAHA.120.315501. Epub 2021 Nov 23. Arterioscler Thromb Vasc Biol. 2022. PMID: 34809449 Free PMC article.
-
Innate and adaptive immunity: the understudied driving force of heart valve disease.Cardiovasc Res. 2021 Nov 22;117(13):2506-2524. doi: 10.1093/cvr/cvab273. Cardiovasc Res. 2021. PMID: 34432007 Free PMC article. Review.
References
-
- Allbutt T. C. (1915). Diseases of the Arteries, Including Angina Pectoris. London: Macmillan
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
